Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David C Perlman

Showing results (71-80 of 118) with videos related to

Pageof 12
Sort By:
Human Pathology|August 9, 2005
Persistent Yersinia pestis antigens in ischemic tissues of a patient with septicemic plagueJeannette Guarner, Wun-Ju Shieh, May Chu, et al.
Journal of Substance Abuse Treatment|March 13, 2012
Assessment of methadone clinic staff attitudes toward hepatitis C evaluation and treatmentAndrew H Talal, Rositsa B Dimova, Randy Seewald, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 4, 2005
The clinical pharmacokinetics of rifampin and ethambutol in HIV-infected persons with tuberculosisDavid C Perlman, Yoninah Segal, Susan Rosenkranz, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 8, 2017
Public Health Benefit of Peer-Referral Strategies for Detecting Undiagnosed HIV Infection Among High-Risk Heterosexuals in New York CityMarya Gwadz, Charles M Cleland, David C Perlman, et al.
The International Journal on Drug Policy|June 9, 2015
An international perspective on using opioid substitution treatment to improve hepatitis C prevention and care for people who inject drugs: Structural barriers and public health potentialDavid C Perlman, Ashly E Jordan, Anneli Uuskula, et al.
Journal of Substance Abuse Treatment|June 28, 2005
Knowledge of hepatitis among active drug injectors at a syringe exchange programJeanne Carey, David C Perlman, Patricia Friedmann, et al.
Frontiers in Public Health|November 30, 2020
The Opioid/Overdose Crisis as a Dialectics of Pain, Despair, and One-Sided StruggleSamuel R Friedman, Noa Krawczyk, David C Perlman, et al.
Substance Use & Misuse|February 8, 2014
A perfect storm: crack cocaine, HSV-2, and HIV among non-injecting drug users in New York CityDon C Des Jarlais, Courtney McKnight, Kamyar Arasteh, et al.
Drug and Alcohol Dependence|March 5, 2015
Longitudinal analysis of pain and illicit drug use behaviors in outpatients on methadone maintenanceLara Dhingra, David C Perlman, Carmen Masson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 7, 2004
The clinical pharmacokinetics of pyrazinamide in HIV-infected persons with tuberculosisDavid C Perlman, Yoninah Segal, Susan Rosenkranz, et al.
Pageof 12

Showing results (71-80 of 118) with videos related to

Sort By:
Pageof 12
Human Pathology|August 9, 2005
Persistent Yersinia pestis antigens in ischemic tissues of a patient with septicemic plagueJeannette Guarner, Wun-Ju Shieh, May Chu, et al.
Journal of Substance Abuse Treatment|March 13, 2012
Assessment of methadone clinic staff attitudes toward hepatitis C evaluation and treatmentAndrew H Talal, Rositsa B Dimova, Randy Seewald, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 4, 2005
The clinical pharmacokinetics of rifampin and ethambutol in HIV-infected persons with tuberculosisDavid C Perlman, Yoninah Segal, Susan Rosenkranz, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 8, 2017
Public Health Benefit of Peer-Referral Strategies for Detecting Undiagnosed HIV Infection Among High-Risk Heterosexuals in New York CityMarya Gwadz, Charles M Cleland, David C Perlman, et al.
The International Journal on Drug Policy|June 9, 2015
An international perspective on using opioid substitution treatment to improve hepatitis C prevention and care for people who inject drugs: Structural barriers and public health potentialDavid C Perlman, Ashly E Jordan, Anneli Uuskula, et al.
Journal of Substance Abuse Treatment|June 28, 2005
Knowledge of hepatitis among active drug injectors at a syringe exchange programJeanne Carey, David C Perlman, Patricia Friedmann, et al.
Frontiers in Public Health|November 30, 2020
The Opioid/Overdose Crisis as a Dialectics of Pain, Despair, and One-Sided StruggleSamuel R Friedman, Noa Krawczyk, David C Perlman, et al.
Substance Use & Misuse|February 8, 2014
A perfect storm: crack cocaine, HSV-2, and HIV among non-injecting drug users in New York CityDon C Des Jarlais, Courtney McKnight, Kamyar Arasteh, et al.
Drug and Alcohol Dependence|March 5, 2015
Longitudinal analysis of pain and illicit drug use behaviors in outpatients on methadone maintenanceLara Dhingra, David C Perlman, Carmen Masson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 7, 2004
The clinical pharmacokinetics of pyrazinamide in HIV-infected persons with tuberculosisDavid C Perlman, Yoninah Segal, Susan Rosenkranz, et al.
Pageof 12